Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Haas

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Medical and Pediatric Oncology|January 1, 1983
Phase II evaluation of galactitol in head and neck cancer: a Southwest Oncology Group StudyC D Haas, D Lehane, R Bottomley
Cancer Treatment Reports|January 1, 1981
Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group StudyC D Haas, L Baker, T Thigpen
Investigational New Drugs|January 1, 1984
Nafazatrom: in-vitro assessment of radiation and drug activity against animal and human cell linesJ S Haas, C D Haas, G W Kyle
Investigational New Drugs|January 1, 1984
Phase I and pharmacologic evaluation of nafazatrom in patients with cancerC D Haas, L H Baker, L J Evans
Cancer Treatment Reports|September 1, 1981
Phase I study on bruceantin administered on a weekly scheduleJ Liesmann, R J Belt, C D Haas, et al.
Cancer|June 1, 1983
Phase I trial of Indicine-N-Oxide on two dose schedulesS Taylor, R J Belt, C D Haas, et al.
Cancer Treatment Reports|May 1, 1981
Phase I evaluation of IMPY in a twice weekly scheduleC D Haas, U Joseph, R J Belt, et al.
Cancer Treatment Reports|May 1, 1976
Phase I evaluation of dianhydrogalactitol (NSC-132313)C D Haas, R L Stephens, M Hollister, et al.
Cancer|August 1, 1980
Studies of hydroxyurea administered by continuous infusion: toxicity, pharmacokinetics, and cell synchronizationR J Belt, C D Haas, J Kennedy, et al.
JAMA|June 16, 1978
Incidence of hemorrhagic complications in patients with cancerR J Belt, C Leite, C D Haas, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Medical and Pediatric Oncology|January 1, 1983
Phase II evaluation of galactitol in head and neck cancer: a Southwest Oncology Group StudyC D Haas, D Lehane, R Bottomley
Cancer Treatment Reports|January 1, 1981
Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group StudyC D Haas, L Baker, T Thigpen
Investigational New Drugs|January 1, 1984
Nafazatrom: in-vitro assessment of radiation and drug activity against animal and human cell linesJ S Haas, C D Haas, G W Kyle
Investigational New Drugs|January 1, 1984
Phase I and pharmacologic evaluation of nafazatrom in patients with cancerC D Haas, L H Baker, L J Evans
Cancer Treatment Reports|September 1, 1981
Phase I study on bruceantin administered on a weekly scheduleJ Liesmann, R J Belt, C D Haas, et al.
Cancer|June 1, 1983
Phase I trial of Indicine-N-Oxide on two dose schedulesS Taylor, R J Belt, C D Haas, et al.
Cancer Treatment Reports|May 1, 1981
Phase I evaluation of IMPY in a twice weekly scheduleC D Haas, U Joseph, R J Belt, et al.
Cancer Treatment Reports|May 1, 1976
Phase I evaluation of dianhydrogalactitol (NSC-132313)C D Haas, R L Stephens, M Hollister, et al.
Cancer|August 1, 1980
Studies of hydroxyurea administered by continuous infusion: toxicity, pharmacokinetics, and cell synchronizationR J Belt, C D Haas, J Kennedy, et al.
JAMA|June 16, 1978
Incidence of hemorrhagic complications in patients with cancerR J Belt, C Leite, C D Haas, et al.
Pageof 4